From Protocol to Price: How to Design Trials HTA Bodies Will Fund

Event Host

Event Description

A candid, cross-market conversation with German and French HTA experts—moderated by Remap—on turning clinical evidence into reimbursable value.

Join Remap Consulting for a 60-minute fireside chat with German and French HTA experts. We’ll tackle the traps that sink price & access: mis-aligned comparators, shaky surrogates, cross-over headaches, and evidence sequencing for EU JCA and national decisions.

What to expect from our discussion:

• Turn “regulatory-ready” into “payer-ready” before FPI.
• Make comparator choices that stand up in DE & FR.
• Use PROs & surrogates that influence price, not just labels.
• Handle cross-over and external controls credibly.
• Time your evidence for JCA & national HTA without delays.